Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Neuropharmacology. 2012 Nov 16;67C:233–242. doi: 10.1016/j.neuropharm.2012.11.008

Figure 1.

Figure 1

Effects of peripherally-administered nicotinic antagonists on inhibitory avoidance memory tested 7 days after training. (A) MLA doses of 2 and 5, but not 0.5 mg/kg, significantly impaired memory. (*) ps < .05 vs. saline. Ns = 8. (B) DHβE doses of 2 and 5, but not 0.5 mg/kg, significantly impaired memory. (*) ps < .05 vs. saline. Ns = 8.